Fertility Preservation Before Cancer Treatment: What Patients Should Know
Updated: Aug 20
A Practical Guide to Protecting Fertility Before Chemotherapy, Radiotherapy, or Surgery

Why Does Early Discussion About Fertility Matters ?
A cancer diagnosis requires urgent and complex decision-making. While the primary focus is often on survival and treatment efficacy, future fertility is an essential aspect of long-term survivorship that should not be overlooked.
Fertility preservation prior to cancer treatment represents a critical step for patients who wish to maintain the possibility of having children in the future. Early discussion and timely intervention can significantly improve reproductive outcomes and quality of life after treatment.
What Do International Guidelines Say About Fertility Preservation Before Cancer Treatment?
Leading organizations including the American Society of Clinical Oncology, European Society for Medical Oncology, National Comprehensive Cancer Network, and American Society for Reproductive Medicine strongly recommend:
✔ Early discussion of infertility risks
✔ Referral to fertility specialists before treatment
✔ Offering fertility preservation to all eligible patients
👉 Importantly, these recommendations apply to both men and women of reproductive age.
Mechanisms of Treatment-Related Infertility
Cancer therapies may impair fertility through direct gonadal toxicity or disruption of the hypothalamic–pituitary–gonadal axis.
High-risk treatments include:
Chemotherapy (especially alkylating agents causing ovarian/testicular failure)
Radiation therapy (dose-dependent gonadal damage, particularly pelvic irradiation)
Surgical resection of reproductive organs
Hematopoietic stem cell transplantation, often associated with high-dose conditioning regimens.
📌 The degree of reproductive damage depends on age, baseline reproductive function,
treatment type, cumulative dose, and the radiation field.
Evidence-Based Fertility Preservation Options
For Women
✔ Oocyte Cryopreservation (Egg Freezing)
No partner required
An established option,wiith outcomes influenced by age and the number of oocytes stored.
✔ Embryo Cryopreservation
Long-established with robust outcomes
Requires sperm source
✔ Ovarian Tissue Cryopreservation
Now considered non-experimental by ASRM
Particularly useful when urgent treatment is required
For Men
✔ Sperm Cryopreservation
Standard of care across all major guidelines (ASCO, NCCN)
Rapid, accessible, and highly effective
⏱️ Timing: A Critical Window
Fertility preservation should ideally be discussed before systemic therapy begins. Many fertility-preservation procedures can be completed within approximately two weeks; however, the safety of any treatment delay must be assessed individually by the oncology and reproductive medicine teams.
Controlled ovarian stimulation and oocyte or embryo cryopreservation
Sperm collection and cryopreservation
Multidisciplinary treatment planning
Discussing fertility preservation early... Starting cancer treatment early can help patients access more options
Gaps in Real-World Practice
Despite clear guideline recommendations, studies show that a significant proportion of patients are not counseled about fertility risks in a timely manner.
This represents a major gap in quality cancer care.
Clinical Implications
You should proactively discuss fertility preservation if:
The patient is of reproductive age
Future childbearing is a consideration
Gonadotoxic therapy is planned
👉 Early counseling allows informed, patient-centered decision-making without compromising oncologic outcomes.
Role of a Second Opinion in Fertility-Sensitive Cases
A oncology second opinion can help:
Review the proposed cancer treatment and its potential impact on fertility
Confirm whether fertility preservation should be considered before treatment
Identify treatment questions that require discussion with a fertility specialist
Support coordination between the oncology and reproductive medicine teams
Provide clear, evidence-based recommendations without unnecessarily delaying cancer treatment
Take Action Before Treatment Starts
Fertility preservation is time-sensitive but often feasible.
👉 Missing this window may lead to irreversible loss of reproductive potential.
If you need clarity before starting treatment:
Speak with your oncology team promptly and request an urgent referral to a reproductive medicine specialist. If questions remain about the diagnosis or proposed treatment plan, consider obtaining an independent oncology second opinion before treatment begins.
References
American Society for Reproductive Medicine. Fertility preservation in people with cancer: ASCO Guideline Update.Journal of Clinical Oncology.2025
Castillo J, Davis AM, Burns KC. Fertility Preservation in People With Cancer. Published online JAMA 2026.
American Society for Reproductive Medicine. Fertility preservation in patients with medical indications: A Committee Opinion. 2026.
Medical Oncologist & Hematologist
If you would like an expert, evidence-based cancer second opinion online, you can request a comprehensive review
For inquiries: info@iconsecondopinion.com
_edited_edited.png)


Comments